Scott Andrew Smith
CIK 1614975 · Chief Executive Officer · last filed 2026-03-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.19M
Companies
6
Total Filings
86
Lifetime Open-Market Net
-$760.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VTRS | Chief Executive Officer | 1,331,759 | $16.48 | $21.95M | $756.0K | 8 | 2026-03-10 |
| BCAB | Director | 321,550 | $3.86 | $1.24M | -$1.57M | 44 | 2025-06-18 |
| Apexigen, Inc. (APGNW) Delisted | Director | — | $0.03 | — | $0 | 1 | 2022-10-03 |
| F-star Therapeutics, Inc. (SBPH) Delisted | Director | 37,476 | — | — | $49.1K | 8 | 2020-06-25 |
| CELGENE CORP /DE/ (CELGZ) Delisted | See Remarks | 54,536 | — | — | $0 | 23 | 2018-02-20 |
| TITAN PHARMACEUTICALS INC (TTNP) Delisted | Director | — | $4.61 | — | $0 | 1 | 2017-09-19 |
Recent Filings · Page 6 of 9
86 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-07 | BCAB | Sell (S) | −2,994 | -$90.4K | EDGAR |
| 2021-08-30 | BCAB | Sell (S) | −33,244 | -$1.33M | EDGAR |
| 2021-06-16 | BCAB | Other (J) | +34,963 | $0 | EDGAR |
| 2020-12-17 | BCAB | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-02 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2019-10-01 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | +5,741 | $0 | EDGAR |
| 2019-07-11 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-01 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | +5,352 | $0 | EDGAR |
| 2019-06-28 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +12,000 | $49.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.